SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla moves up on the BSE

11 Jul 2014 Evaluate

Cipla is currently trading at Rs. 435.20, up by 0.20 points or 0.05% from its previous closing of Rs. 435.00 on the BSE.

The scrip opened at Rs. 433.00 and has touched a high and low of Rs. 444.80 and Rs. 430.50 respectively. So far 101285 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 460.45 on 08-Jul-2014 and a 52 week low of Rs. 366.70 on 24-Feb-2014.

Last one week high and low of the scrip stood at Rs. 460.45 and Rs. 425.90 respectively. The current market cap of the company is Rs. 35043.50 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 34.75% and 27.35% respectively.

Cipla, in collaboration with the UK government, has expressed its intention to make investments of up to 100 million pounds in its UK subsidiary over the next few years. The investments are expected to facilitate the launch of a range of products in the area of respiratory, oncology and antiretroviral medicines to further Cipla’s higher purpose of universal affordable access.

The company also plans to invest in R&D activities, clinical trials and expand further internationally. The investment underscores the growing importance of UK in the company’s long term strategy.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.

Cipla Share Price

1238.30 7.55 (0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×